$42.96 -0.46 (-1.06%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - New York Stock Exchange, Inc.

Sep. 26, 2016 | 04:00 PM
Last Trade: 42.96
Trade Time: Sep 26 04:00 PM Eastern Daylight Time
Change: -0.46 (-1.06%)
Prev Close: 43.42
Open: 43.09
Bid: 42.93
Ask: 43.01
  1. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 13:20PM EST
  2. Alphabet-Glaxo Joint Venture Targets 'Bioelectronics'

    Investors Business Daily | Aug. 1, 2016 | 10:13AM EST
  3. Veeva Is Key Partner In Big Pharma's Race Against The Clock

    Investors Business Daily | Jul. 29, 2016 | 08:00AM EST
  4. Stock Futures Up, Gaining Strength; Apple Hauls Techs Higher

    Investors Business Daily | Jul. 27, 2016 | 08:00AM EST
  5. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  6. Getting to Know VBI Vaccines

    GuruFocus | Jul. 13, 2016 | 13:04PM EST
  7. Brandes Makes a Variety of Reductions in 4th Quarter

    GuruFocus | Feb. 11, 2016 | 18:19PM EST
  8. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  9. EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4

    Benzinga | Jan. 29, 2016 | 13:38PM EST
  10. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  11. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  12. Stocks Bring High Dividend Yields to HOTCHKIS & WILEY

    GuruFocus | Jan. 14, 2016 | 12:05PM EST
  13. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  14. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  15. Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Jan. 4, 2016 | 17:46PM EST
Trading Center